AEON Biopharma, Inc.
General ticker "AEON" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $10.9M (TTM average)
AEON Biopharma, Inc. does not follow the US Stock Market performance with the rate: -30.5%.
Estimated limits based on current volatility of 8.9%: low 0.20$, high 0.24$
Factors to consider:
- Current price 59.4% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.48$, 2.95$]
- 2026-12-31 to 2027-12-31 estimated range: [0.33$, 2.06$]
Short-term AEON quotes
Long-term AEON plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $12.80MM |
| Operating Income | $-12.80MM |
| Non-Operating Income | $-26.42MM |
| R&D Expense | $4.09MM |
| Income(Loss) | $-39.22MM |
| Net Income(Loss)* | $-39.22MM |
| Stockholders Equity | $-55.03MM |
| Assets | $5.56MM |
| Operating Cash Flow | $-17.31MM |
| Capital expenditure | $0.00MM |
| Investing Cash Flow | $-0.00MM |
| Financing Cash Flow | $20.30MM |
| Earnings Per Share** | $-3.95 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.